EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cardiometabolic Factors and Breast Cancer: A Case-Control Study in Women

Niki Mourouti, Christos Papavagelis, Meropi D. Kontogianni, Petrini Plytzanopoulou, Tonia Vassilakou, Nikolaos Malamos, Athena Linos, Demosthenes B. Panagiotakos

The Open Hypertension Journal · 2013

DOI: 10.2174/1876526201305010049 ↗
AbstractBibliografische Angaben

Abstract

Background: Previous studies have suggested that individual cardiometabolic factors may be associated with an increased risk of breast cancer. Objective: To evaluate the association between individual cardiometabolic factors with breast cancer development. Design: A case – control study. Two-hundred-and-fifty consecutive, newly diagnosed breast cancer female patients (56±12 years) and 250, one-to-one age-matched with the patients, healthy volunteers (controls), were studied. A standardized, validated questionnaire assessing various socio-demographic, clinical, lifestyle and dietary characteristics, was applied through face-to-face interviews. Adherence to the Mediterranean diet was evaluated using the 11-components MedDietScore (theoretical range 0-55). A detailed medical history regarding the common co-morbidities (i.e., diabetes, hypertension, hypercholesterolemia) and their treatment was also recorded, while women were also categorized using the Body Mass Index (BMI) as an indicator of obesity. Results: Obesity (i.e., BMI>30 kg/m2) was positively associated with the likelihood of having breast cancer. Conclusions: With the exception of obesity, none of the other tested cardiometabolic risk factors seemed to be a predisposing factor for breast cancer development.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →